Helicobacter pylori eradication using tetracycline and furazolidone versus amoxicillin and azithromycin in lansoprazole based triple therapy: An open randomized clinical trial

Arquivos de Gastroenterologia

Volumn 42, Issue 2, 2005, Pages 111-115

  Frota, Laura Cidrão ^a   Da Cunha, Maria Do Perpétuo Socorro Saldanha ^a   Luz, Carlos René Lima ^a   De Araujo Filho, Antonio Haroldo ^a   Frota, Luciano A S ^a   Braga, Lucia Libanez Bessa Campelo ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BISMUTH SALT; CARBON 14; CLARITHROMYCIN; FURAZOLIDONE; LANSOPRAZOLE; NITROIMIDAZOLE DERIVATIVE; OMEPRAZOLE; OXYTETRACYCLINE; PROTON PUMP INHIBITOR; RANITIDINE; TETRACYCLINE; UREASE;

ADULT; ARTICLE; BRAZIL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UREA BREATH TEST;

EID: 23744506840     PISSN: 00042803     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-28032005000200009     Document Type: Article

References (32)

1. al-Assi MT, Genta RM, Karttunen TJ, Cole KA, Graham DY. Azithromycin triple therapy for Helicobacter pylori infection: azithromycin, tetracycline, and bismuth. Am J Gastroenterol 1995;90:403-5.
2. Anagnostopoulos GK, Kostopoulos P, Margantinis G, Tsiakos S, Arvanitidis D. Omeprazole plus azithromycin and either amoxicillin or tinidazole for eradication of Helicobacter pylori infection. J Clin Gastroenterol 2003;36:325-8.
3. Bertoni G, Sassatelli R, Nigrisoli E, Tansini P, Blanche G, Delia Casa G, Bagni A, Bedogni G. Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin. Am J Gastroenterol 1996;9:258-63.
4. Blandizzi C, Malizia T, Gherardi G, Costa F, Marchi S, Marveggio C, Natale G, Senesi S, Bellini M, Maltinti G, Campa M, Del Tacca M. Gastric mucosa distribution and clinical efficacy of azithromycin in patients with Helicobacter pylori related gastritis. J Antimicrob Chemother 1998;42:75-82.
5. Calvet X, Garcia N, Lopez T, Gisbert JP, Gene E, Roque K. A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxicillin for treating Helicobacter pylori infection. Aliment Pharmacol Ther 2000;14:603-9.
6. Cammarota G, Tursi A, Papa A, Montatto M, Veneto G, Cuoco L, Fedeli G, Gasbamini G. Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxicillin and either clarithromycin or azithromycin. Aliment Pharmacol Ther 1996;10:997-1000.
7. Chey WD, Fisher L, Barnett J, Delvalle J, Elta GH, Hasler WL, Nostrant T, Palaniappan J, Sheiman J. Low-versus high-dose azithromycin triple therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1998;12:1263-7.
8. Coelho LGV, Vieira WLS, Passos MCF. Azithromycin, furazolidone and omeprazole: a promising low-dose, low-cost, short-term anti H. pylori triple therapy [abstract]. Gastroenterology 1998;1196:296A.
9. Dani R, Queiroz DM, Dias MG, Franco JM, Magalhães LC, Mendes GS, Moreira LS, De Castro LP, Toppa NH, Rocha GA, Cabrai MM, Sales PG. Omeprazole, clarithromycin and furazolidone for the eradication of Helicobacter pylori in patients with duodenal ulcer. Aliment Pharmacol Ther 1999;13:1647-52.
10. de Boer WA, Thys JC, Borody TJ, Graham DY, O'Morain C, Tytgat GN. Proposal for use of a standard side effect scoring system in studies exploring Helicobacter pylori treatment regimens. Eur J Gastroenterol Hepatol 1996;8:641-3.
11. Di Mario F, Dal Bo N, Grassi SA, Rugge M, Cassaro M, Donisi PM, Vianello F, Kusstatscher S, Salandin S, Grasso GA, Ferrana M, Battaglia G. Azithromycin for the cure of Helicobacter pylori infection. Am J Gastroenterol 1996;91:264-7.
12. The European Helicobacter pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997;41:8-13.
13. Fennerty MB. What are the treatment goals for Helicobacter pylori infection? Gastroenterology 1997;113:120-5.
14. Graham DY. Antibiotic resistance in Helicobacter pylori: implications for therapy. Gastroenterology 1998;115:1272-7.
15. Graham DY, Osato MS, Hoffman J, Opikun AR, Anderson SY, El-Zimaity HM. Furazolidone combination therapies for Helicobacter pylori infection in the United States. Aliment Pharmacol Ther 2000;14:211-5.
16. Hopkins S. Clinical toleration and safety of azithromycin. Am J Med 1991;91(Suppl 3A):40-5.
17. Hulten K, Cars O, Hjelm E, Engstrand L. In-vitro active of azitromycin against intracellular Helicobacter pylori. J Antimicrob Chemother 1996;37:483-9
18. Ivashkin VT, Lapina TL, Bondarenko OY, Sklanskaya OA, Grigoriev PY, Vasiliev YV, Yakovenko EP, Gulyaev PV, Fedchenko VI. Azithromycin in a triple therapy for H.pylori eradication in active duodenal ulcer. World J Gastroenterol 2002;8:879-82.
19. Laine L, Estrada R, Trujillo M, Cheybani K, Yeeramian P, Smith S, Neil G. Once-daily therapy for H. pylori infection: a randomized comparison of four regimens. Am J Gastroenterol 1999;94:962-6.
20. Liu WZ, Xiao, SD, Shi Y, Wu SM, Zhang DZ, Xu WW, Tytgat GN. Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther 1999;13:317-22.
21. Lombardo L, Masoero G, Dela Monica D, Pera A. Helicobacter pylori eradication using one-week low-dose lansoprasole plus amoxicillin and azithromycin: failure of a "promising" association [letter]. Ital J Gastroenterol Hepatol 1999;31:266-7
22. Malekzadeh R, Merat S, Derakhshan MH, Siavoshi F, Yazdanbod A, Mikaeli J, Sotoudemanesh R, Sotoudeh M, Farahvash MJ, Nasseri-Moghaddam S, Pourshams A, Dolatshahi S, Abedi B, Babaei M, Arshi S, Majidpour A. Low Helicobacter pylori eradication rates with 4- and 7-day regimens in an Iranian population. J Gastroenterol Hepatol 2003;18:13-7.
23. Mansour-Ghanaei F, Fallah MS, Shafaghi A. Eradication of Helicobacter pylori in duodenal ulcer disease tetracycline & furazolidone vs. metronidazole & amoxicillin in omeprazole based triple therapy. Med Sci Monit 2002;8:P127-30
24. Megraud F. Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori. Gastroenterology 1998;115:1278-82
25. Mendonca S, Ecclissato C, Sartori MS, Godoy AP, Guerzoni RA, Degger M, Pedrazzoli Jr. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil. Helicobacter 2000;5:79-83.
26. Peitz U, Menegatti M, Vaira D, Malfertheiner P. The European meeting on Helicobacter pylori: therapeutic news from Lisbon. Gut 1998;43:66-9.
27. 14C-urea breath test offers diagnosis of Helicobacter pylori m 10 minutes. Am J Gastroenterol 1996;91:233-8.
28. Silva FM, Eisig JN, Chehter EZ, Silva JJ, Laudanna AA. Omeprazole, furazolidone, and tetracycline: an eradication treatment for resistant H. pylori in Brazilian patients with peptic ulcer disease. Rev Hosp Clin Fac Med São Paulo 2002;57:205-8.
29. Trevisani L, Sartori S, Caselli M, Ruina M, Verdianelli G, Abbasciano V. A four-day low dose triple therapy regimen for the treatment of Helicobacter pylori infection. Am J Gastroenterol 1998;93:390-3.
30. Trevisani L, Sartori S, Galvani F, Ruina M, Caseli M, Verdianelli G, Abbasciano V. Evaluation of a new ultrashort triple therapy for Helicobacter pylori disease. Aliment Pharmacol Ther 1998;12:1269-72.
31. Vcev A, Vceva A, Stimac D, Takac B, Dmitrovic B, Stimac D, Stimac T, Kovac D, Pezerovic D, Blazanovic A, Ivandic A, Karner J. Omeprazole, azithromycin and either amoxicillin or metronidazole in eradication of Helicobacter pylori in duodenal ulcer patients. Aliment Pharmacol Ther 1998;12:453-6.
32. Vcev A, Stimac D, Ivandic A, Vceva A, Takac B, Pezerovic D. Pantoprazole, amoxicillin and either azithromycin or clarithromycin for eradication of Helicobacter pylori in duodenal ulcer. Aliment Pharmacol Ther 2000;14:69-72.